AVIR EPS Estimates
Atea Pharmaceuticals, Inc.
$4.64
+$0.01(+0.22%)
38
Overall
60
Value
20
Tech
34
Quality
Market Cap
$371.35M
Volume
3.65K
52W Range
$2.87 - $6.45
Target Price
$8.50
AVIR EPS estimates: the consensus estimate for Atea Pharmaceuticals, Inc.'s current fiscal year is -$1.99 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
AVIR EPS Estimates
- EPS estimate, current quarter
- $-0.50
- EPS estimate, next quarter
- $-0.57
- EPS estimate, current year
- $-1.99
- EPS estimate, next year
- $-1.48
- EPS growth, 3-year
- -11.75%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.94 |
| 2024 | $-2.00 |
| 2023 | $-1.63 |
| 2022 | $-1.39 |
| 2021 | $1.46 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVIR | $4.64 | +0.2% | 3.65K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Atea Pharmaceuticals, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW